相似文献
1
Overdiagnosis in the Age of Digital Cancer Screening.
J Natl Cancer Inst. 2021 Jan 4;113(1):1-2. doi: 10.1093/jnci/djaa081.
2
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Ann Intern Med. 2016 Feb 16;164(4):256-67. doi: 10.7326/M15-0970. Epub 2016 Jan 12.
3
Overdiagnosis in breast imaging.
Breast. 2017 Feb;31:270-273. doi: 10.1016/j.breast.2016.10.011. Epub 2016 Oct 28.
4
Estimation of overdiagnosis by detection to incidence ratio in cancer screening.
J Med Screen. 2019 Sep;26(3):135-138. doi: 10.1177/0969141319842910. Epub 2019 Apr 16.
5
Breast cancer: The importance of overdiagnosis in breast-cancer screening.
Nat Rev Clin Oncol. 2016 Jan;13(1):5-6. doi: 10.1038/nrclinonc.2015.203. Epub 2015 Nov 17.
6
Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening.
Int J Cancer. 2019 Aug 15;145(4):994-1006. doi: 10.1002/ijc.32211. Epub 2019 Mar 14.
7
Breast Cancer Screening in Average-Risk Women.
Ann Intern Med. 2019 Apr 16;170(8). doi: 10.7326/P19-0007. Epub 2019 Apr 9.
8
Physicians discuss ramifications of studies pointing to breast cancer overdiagnosis: New research under way attempts to better define who should be screened and treated.
Cancer. 2017 Dec 1;123(23):4525-4527. doi: 10.1002/cncr.31118.
9
Breast cancer incidence trends in Norway and estimates of overdiagnosis.
J Med Screen. 2017 Jun;24(2):83-91. doi: 10.1177/0969141316668379. Epub 2016 Oct 17.
10
Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.
Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.
引用本文的文献
1
Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2023 Dec 19;23(9):1-293. eCollection 2023.
2
Cancer overdiagnosis: a challenge in the era of screening.
J Natl Cancer Cent. 2022 Dec;2(4):235-242. doi: 10.1016/j.jncc.2022.08.005. Epub 2022 Aug 21.
3
Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms.
Int J Environ Res Public Health. 2022 Nov 8;19(22):14647. doi: 10.3390/ijerph192214647.
4
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial.
J Natl Cancer Inst. 2021 Nov 2;113(11):1523-1530. doi: 10.1093/jnci/djab083.
5
Disparities in Cancer Prevention in the COVID-19 Era.
Cancer Prev Res (Phila). 2020 Nov;13(11):893-896. doi: 10.1158/1940-6207.CAPR-20-0447. Epub 2020 Sep 17.
本文引用的文献
1
Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis.
J Natl Cancer Inst. 2021 Jan 4;113(1):16-26. doi: 10.1093/jnci/djaa080.
2
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx.
J Clin Oncol. 2019 Aug 1;37(22):1956-1964. doi: 10.1200/JCO.19.00945. Epub 2019 May 31.
3
Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
BMJ. 2017 Dec 5;359:j5224. doi: 10.1136/bmj.j5224.
4
Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
N Engl J Med. 2015 Oct 29;373(18):1685-7. doi: 10.1056/NEJMp1510443.
Zotero 插件